Systematic review and meta-analysis of breast density and metabolic factors in ductal carcinoma in situ

Factors associated with ductal carcinoma in situ (DCIS) initiation, progression to invasive breast cancer, and recurrence of ipsilateral DCIS or invasive breast cancer following treatment are poorly understood. Understanding how systemic and local microenvironment-related factors influence DCIS biology may improve risk stratification and help to distinguish lesions likely to remain indolent from those at high risk of progressing to invasive breast cancer. Systematic review and meta-analysis of published studies evaluated associations between breast density, metabolic risk factors, adipocyte-related measures, and background parenchymal enhancement (BPE) with DCIS outcomes. The analysis included 35 studies comprising 47,796 new DCIS diagnoses or ipsilateral invasive breast cancer (iIBC) diagnoses. Higher mammographic breast density was consistently associated with increased risk of DCIS initiation across menopausal subgroups (pooled relative effect 2.36; 95% CI 1.79-3.11), with supporting studies generally at low risk of bias. Higher BMI was associated with lower risk of DCIS initation in premenopausal women (0.74; 95% CI 0.63-0.87), whereas an opposite but non-significant association was observed in postmenopausal women (1.17; 0.99-1.37). Evidence regarding adipocyte-related measures, metabolic risk factors beyond BMI, and recurrence outcomes was limited and heterogeneous. No eligible studies evaluated progression to invasive breast cancer after untreated DCIS. The authors conclude that these findings support a role for breast density and adipocyte-related factors in early DCIS development. Evidence regarding progression and recurrence remains sparse.